GOLD -ABE classification: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
It can be downloaded in pdf format: | It can be downloaded in pdf format: | ||
<pdf>File:GOLD_ABE.pdf</pdf> | |||
[[File:GOLD ABE.png|alt=GOLD ABE classification|center|frameless|700px]] | [[File:GOLD ABE.png|alt=GOLD ABE classification|center|frameless|700px]] | ||
{{Voir|Article cible=Chronic obstructive pulmonary disease (COPD)}} | {{Voir|Article cible=Chronic obstructive pulmonary disease (COPD)}} | ||
Revision as of 14:12, 9 October 2023
The GOLD - ABE (Global initiative for chronic Obstructive Lung Disease ABE) classification is a clinical and spirometric severity scale for chronic obstructive pulmonary disease (COPD). Its prognostic and therapeutic implications make it widely used in routine clinical practice. Historically limited to a single GOLD grading, it has become more complex with the addition of a therapeutic grading ABCD then ABE (since 2023) to the GOLD grading, which is now limited to establishing the diagnosis. See specific chapters on COPD and respiratory function tests (RFTs).
It can be downloaded in pdf format:
Author(s)
Dr Shanan Khairi, MD
Bibliography
GOLD, At a glance outpatient management reference for chronic obstructive pulmonary disease (CPOD), 2015
Agusti A et al., GOLD 2023 : Highlights for primary care, npj Primary Care Respiratory Medicine, 2023